Prevalence of Staphylococcus spp. nasal colonization among doctors of podiatric medicine and associated risk factors in Spain

Antimicrobial Resistance and Infection Control
Sheila de BenitoDavid Sevillano

Abstract

This study aimed to estimate the prevalence of methicillin-susceptible and -resistant Staphylococcus aureus (MSSA and MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE) nasopharyngeal carriage among Doctors of Podiatric Medicine (Podiatrists) and to determine the potential risk factors. A cross-sectional study was carried out in 2016-2017 among 239 podiatrists in Spain. The presence of MSSA, MRSA, and MRSE was determined by microbiological analysis of nasal exudate and antimicrobial susceptibility was determined. Each podiatrist completed a questionnaire. The questionnaire comprised various parameters such as sex, age, podiatry experience duration, underlying diseases, prior antibiotic treatment, hospitalization during the last year, and use of a protective mask, an aspiration system, or gloves. The prevalence of MSSA, MRSA, and MRSE was 23.0%, 1.3%, and 23.8%, respectively. The MSSA prevalence was higher among podiatrists who did not use an aspiration system (32.3%) compared to those who did (19.3%; p = 0.0305), and among podiatrists with respiratory diseases (36.8%) compared to those without (20.8%; p = 0.0272). The MRSE prevalence was higher among men (33.7%) compared to women (8.6%; p = 0.0089), podiatrists a...Continue Reading

References

Jul 1, 1987·Diabetes Care·B A LipskyT D Koepsell
Dec 1, 1967·The Journal of Hygiene·W C NobleC H Wolters
Aug 1, 1995·Epidemiology and Infection·N H EriksenK Jensen
Oct 20, 1998·The Journal of Hospital Infection·Loreen A Herwaldt
Jul 10, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Loreen A HerwaldtTrish M Perl
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Mar 8, 2006·Annals of Internal Medicine·Philip L GrahamElaine L Larson
Oct 7, 2006·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Ender GüçlüErol Egeli
Mar 29, 2008·American Journal of Infection Control·Maria Clara PadovezeMaria Luiza Moretti
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lona ModySuzanne F Bradley
May 16, 2008·Enfermedades infecciosas y microbiología clínica·Oscar CuevasGrupo Español para el Estudio de Estafilococo
Jul 8, 2008·The Journal of Hospital Infection·S J Dancer
Jan 22, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·W J MunckhofP Giffard
Mar 3, 2009·Pharmacotherapy·Kevin W McConeghyKerry L LaPlante
Jul 21, 2010·Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·Naeem Akhtar
May 5, 2012·GMS Krankenhaushygiene interdisziplinär·Guido A GualdoniHeinz Burgmann
Sep 8, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philipp ZangerPeter G Kremsner
Nov 28, 2012·Enfermedades infecciosas y microbiología clínica·Carmen Rodríguez-AvialJuan J Picazo
Jan 27, 2015·Enfermedades infecciosas y microbiología clínica·Albert BoadaBonaventura Bolíbar
May 29, 2015·Journal of Clinical Microbiology·Sophie Trouillet-AssantFrederic Laurent
Oct 31, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C GarciaO Denis
Jul 29, 2016·Nature·Alexander ZippererBernhard Krismer
Dec 27, 2016·International Journal of Medical Microbiology : IJMM·Karsten BeckerPrevalence of Multiresistant Microorganisms PMM Study

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

© 2021 Meta ULC. All rights reserved